LDLR Antikörper (Extracellular Domain)
(1 reference)-
- Target Alle LDLR Antikörper anzeigen
- LDLR (Low Density Lipoprotein Receptor (LDLR))
-
Bindungsspezifität
- Extracellular Domain
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LDLR Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (IHC)
- Aufreinigung
- Immunoaffinity chromatography
- Immunogen
- LDL receptor antibody was raised in rabbit using a synthetic peptide (sequence not conserved in VLDL receptor and LRP) of the LDL receptor extracellular domain as the immunogen.
- Isotyp
- IgG
- Top Product
- Discover our top product LDLR Primärantikörper
-
anti-Low Density Lipoprotein Receptor (LDLR) (AA 22-150) antibody
LDLR Reaktivität: Human WB, ELISA, FACS, IHC, ICC Wirt: Maus Monoclonal 1B10H10 unconjugated
anti-Low Density Lipoprotein Receptor (LDLR) (C-Term) antibodyKO Validated LDLR Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Low Density Lipoprotein Receptor (LDLR) (AA 781-860) antibodyLDLR Reaktivität: Human, Maus, Ratte, Hamster, Pflanzen WB, ELISA, FACS, IF (p), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Low Density Lipoprotein Receptor (LDLR) antibodyLDLR Reaktivität: Human ELISA, FACS, IHC, IF Wirt: Kaninchen Monoclonal 2B10 unconjugated Recombinant Antibody
anti-Low Density Lipoprotein Receptor (LDLR) antibodyLDLR Reaktivität: Human, Maus, Ratte IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Low Density Lipoprotein Receptor (LDLR) antibodyLDLR Reaktivität: Human WB Wirt: Kaninchen Monoclonal unconjugated
anti-Low Density Lipoprotein Receptor (LDLR) (AA 497-742) antibodyLDLR Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Low Density Lipoprotein Receptor (LDLR) (AA 263-509) antibodyLDLR Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Low Density Lipoprotein Receptor (LDLR) (AA 105-205) antibodyLDLR Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 5E7 unconjugated
anti-Low Density Lipoprotein Receptor (LDLR) (AA 335-588) antibodyLDLR Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- FC: 1:10, IHC: 1:20, WB: 1:100-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS with 0.5 % BSA
- Handhabung
- Avoid repeated freeze/thaw cycles
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
: "VEGF-B signaling impairs endothelial glucose transcytosis by decreasing membrane cholesterol content." in: EMBO reports, Vol. 21, Issue 7, pp. e49343, (2020) (PubMed).
-
: "VEGF-B signaling impairs endothelial glucose transcytosis by decreasing membrane cholesterol content." in: EMBO reports, Vol. 21, Issue 7, pp. e49343, (2020) (PubMed).
-
- Target
- LDLR (Low Density Lipoprotein Receptor (LDLR))
- Andere Bezeichnung
- LDL Receptor (LDLR Produkte)
- Synonyme
- FH antikoerper, FHC antikoerper, LDLCQ2 antikoerper, Hlb301 antikoerper, LDLRA antikoerper, LDLA antikoerper, LDL receptor-2 antikoerper, fhc antikoerper, ldlcq2 antikoerper, ldlr antikoerper, ldlr2-a antikoerper, LDL receptor 1 antikoerper, ldlr-a antikoerper, ldlr-b antikoerper, low density lipoprotein receptor antikoerper, low density lipoprotein receptor a antikoerper, low density lipoprotein receptor S homeolog antikoerper, low density lipoprotein receptor L homeolog antikoerper, LDLR antikoerper, Ldlr antikoerper, ldlra antikoerper, ldlr.S antikoerper, ldlr.L antikoerper
- Pathways
- Hepatitis C, Lipid Metabolism
-
